Cost-effectiveness of left atrial appendage closure with the WATCHMAN device compared with warfarin or non-Vitamin K antagonist oral anticoagulants for secondary prevention in nonvalvular atrial fibrillation

Vivek Y. Reddy, Ronald L. Akehurst, Stacey L. Amorosi, Meghan B. Gavaghan, Deanna S. Hertz, David Holmes

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)1464-1470
Number of pages7
JournalStroke
Volume49
Issue number6
DOIs
StatePublished - Jan 1 2018

    Fingerprint

Keywords

  • apixaban
  • atrial fibrillation
  • cost-effectiveness analysis
  • dabigatran
  • left atrial appendage closure
  • warfarin

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Cite this